Q1: 2026-05-07 Earnings Summary EPS of -$0.37 misses by $0.02  |  Revenue of $0.00 beats by $0.00 Amylyx Pharmaceuticals, Inc. ( AMLX ) Bank of America Global Healthcare Conference 2026 May 13, 2026 4:40 PM EDT Company Participants Joshua Cohen - Co-Founder, Co-CEO & Director Conference Call Participants Jason Gerberry - BofA Securities, Research Division Presentation Jason Gerberry BofA Securities, Research Division Company presenter at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I cover pharma and biotech, and I'm pleased to be introducing Amylyx Pharmaceuticals and Joshua Cohen, Co-Chief Executive Officer; This is an interesting time for Amylyx on the cusp of pivotal Phase III data expected in the third quarter, a transformational event. So I imagine a lot of our discussion is going to be focused on the lead program for PBH. So Josh, thanks for joining us. Joshua Cohen Co-Founder, Co-CEO & Director Yes. Thank you so much for having us.…